Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

3A4, a new potential target for B and myeloid lineage leukemias.

Li S, Tang Y, Zhang J, Guo X, Shen H.

J Drug Target. 2011 Nov;19(9):797-804. doi: 10.3109/1061186X.2011.572973. Epub 2011 Apr 20.

PMID:
21504388
2.

[Preparation of the immunotoxin 2E8-norcantharidin and its targeting killing effect in vitro].

Li LX, Tang YM, Zhang HZ, Shen HQ, Qian BQ, Luo CF.

Zhonghua Er Ke Za Zhi. 2008 Jul;46(7):493-7. Chinese.

PMID:
19099803
3.

Preparation and evaluation of norcantharidin-encapsulated liposomes modified with a novel CD19 monoclonal antibody 2E8.

Zhang J, Tang Y, Qian B, Sheng H.

J Huazhong Univ Sci Technolog Med Sci. 2010 Apr;30(2):240-7. doi: 10.1007/s11596-010-0222-1. Epub 2010 Apr 21.

PMID:
20407882
4.
5.

[Reactivity of a novel monoclonal antibody ZCH-2B8a on normal hematopoietic cells and malignant cell lines and its significance].

Tang YM, Guo L, Yang SL, Shen HQ, Qian BQ, Zhang Y, Zhang HZ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Oct;14(5):990-4. Chinese.

PMID:
17096904
6.

Accurate determination of internalization for target binding antibody using papain digestion and flow cytometry.

Li S, Tang Y.

Hybridoma (Larchmt). 2010 Apr;29(2):133-9. doi: 10.1089/hyb.2009.0071.

PMID:
20443705
7.

A comprehensive surface proteome analysis of myeloid leukemia cell lines for therapeutic antibody development.

Strassberger V, Gutbrodt KL, Krall N, Roesli C, Takizawa H, Manz MG, Fugmann T, Neri D.

J Proteomics. 2014 Mar 17;99:138-51. doi: 10.1016/j.jprot.2014.01.022. Epub 2014 Jan 30.

PMID:
24487095
8.

Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia.

Pagel JM, Matthews DC, Kenoyer A, Hamlin DK, Wilbur DS, Fisher DR, Gopal AK, Lin Y, Saganic L, Appelbaum FR, Press OW.

Cancer Res. 2009 Jan 1;69(1):185-92. doi: 10.1158/0008-5472.CAN-08-2513.

9.

[Targeted killing of the Nalm-6 cells with 2E8-Genistein immunotoxin and its mechanism].

Chen YH, Tang YM, Shen HQ, Song H, Yang SL, Shi SW, Qian BQ, Xu WQ, Ning BT.

Zhonghua Er Ke Za Zhi. 2009 Jan;47(1):57-61. Chinese.

PMID:
19573385
10.

Preclinical studies targeting normal and leukemic hematopoietic cells with Yttrium-90-labeled anti-CD45 antibody in vitro and in vivo in nude mice.

Vallera DA, Elson M, Brechbiel MW, Dusenbery KE, Burns LJ, Skubitz KM, Jaszcz WB, Ramsay NK, Panoskaltsis-Mortari A, Kuroki DW, Wagner JE, Kersey JH.

Cancer Biother Radiopharm. 2003 Apr;18(2):133-45.

PMID:
12804039
11.

[Reactivity of a novel monoclonal antibody ZCH-7-2D3 on leukemia cells and its clinical significance].

Guo L, Tang YM, Shen HQ, Qian BQ, Ning BT, Zhang HZ, Zhang Y.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2006 Jul;35(4):390-3. Chinese.

PMID:
16924702
12.

Immunosuppressive effects of (131)I-anti-CD45 antibody in unsensitized and donor antigen-presensitized H2-matched, minor antigen-mismatched murine transplant models.

Ruffner KL, Martin PJ, Hussell S, Nourigat C, Fisher DR, Bernstein ID, Matthews DC.

Cancer Res. 2001 Jul 1;61(13):5126-31.

13.
14.

ZCH-2B8a, an antibody targeting actin-binding protein coronin-1a, is a potential therapeutic agent for B-lineage malignancies.

Xu XJ, Tang YM, Zhao HZ, Guo L, Wang ZJ.

J Drug Target. 2014 Jul;22(6):488-97. doi: 10.3109/1061186X.2014.888072. Epub 2014 Feb 19.

PMID:
24547769
15.

Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model.

Pagel JM, Kenoyer AL, Bäck T, Hamlin DK, Wilbur DS, Fisher DR, Park SI, Frayo S, Axtman A, Orgun N, Orozco J, Shenoi J, Lin Y, Gopal AK, Green DJ, Appelbaum FR, Press OW.

Blood. 2011 Jul 21;118(3):703-11. doi: 10.1182/blood-2011-04-347039. Epub 2011 May 25.

17.

Definition of the specificity of monoclonal antibodies against porcine CD45 and CD45R: report from the CD45/CD45R and CD44 subgroup of the Second International Swine CD Workshop.

Zuckermann FA, Peavey C, Schnitzlein WM, Schabacker D, Husmann RJ, Yang H, Saalmüller A, Lunney JK.

Vet Immunol Immunopathol. 1998 Jan 30;60(3-4):367-87.

PMID:
9589574
19.
20.

PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule.

Falini B, Flenghi L, Pileri S, Gambacorta M, Bigerna B, Durkop H, Eitelbach F, Thiele J, Pacini R, Cavaliere A, et al.

Am J Pathol. 1993 May;142(5):1359-72.

Supplemental Content

Support Center